ClinicalTrials.Veeva

Menu

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study (RESTOREb)

Spark Biomedical logo

Spark Biomedical

Status

Completed

Conditions

Opioid Use Disorder
Relapse

Treatments

Behavioral: Clinical Outcomes and Questionnaires

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT05591703
SBM-OWP-03b

Details and patient eligibility

About

This is a prospective, observational, longitudinal study to assess clinical outcomes in the 12-months following participants' exit from protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE; ClinicalTrials.gov Identifier: NCT05053503). Clinical outcome scores will be collected at study exit from protocol SBM-OWP-03, 1 month, 3 months, 6 months, 9 months, and 12 months after study exit from protocol SBM-OWP-03.

Enrollment

32 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Consented participant for protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE)
  2. Participant is English proficient
  3. Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements

Exclusion criteria

  1. Participant is unable to reliably receive and respond to assessments via email or telephone
  2. Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial

Trial design

32 participants in 2 patient groups

Participants randomized to receive tAN therapy in SBM-OWP-03 Phase II
Treatment:
Behavioral: Clinical Outcomes and Questionnaires
Participants not randomized to receive tAN therapy in SBM-OWP-03 Phase II
Treatment:
Behavioral: Clinical Outcomes and Questionnaires

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems